Open access peer-reviewed chapter

Sweet Solution Analgesia

Written By

Khawla Nuseir, Manal Kassab and Mohammed Al-Azzani

Submitted: 20 May 2016 Reviewed: 27 October 2016 Published: 24 May 2017

DOI: 10.5772/66596

From the Edited Volume

Pain Relief - From Analgesics to Alternative Therapies

Edited by Cecilia Maldonado

Chapter metrics overview

1,636 Chapter Downloads

View Full Metrics


Mammals’ first tasting experience is usually sweet solution. Whether it is milk (breast or formula), sugar water as in some cultures or even dates as advocated by Prophet Mohammed to his followers. Thus, it is no wonder the soothing, calming and even pain relieving effects of oral sweet solutions. Nevertheless, using sweet solution purposely for its pain-relieving effects for infants in the clinical setting is relatively recent; however, the discussion concerning sweet solution effectiveness, mechanism of actions and adverse long-term effects are still ongoing. In this chapter, we present an account of studies on both humans and animals that explored and examined the use of several sweet solutions for analgesia.


  • premature
  • infants
  • pain
  • NICU
  • sucrose

1. Introduction

Young children are subjected to undergo many painful medical procedures early in their life. Althoughthese procedures are performed even in healthy children, they are more common in sick ones who need an admission to the hospital. Treating pain in the newborn is essential; firstly, for ethical reasons and, secondly, because pain can lead to several physiological and psychological effects. Not only such negative consequences are not related to repeated painful procedures but even short-term pain can have lasting negative effects [1]. Young children, including neonates, are more sensitive to nociceptive stimuli than adults [2]. Research findings emphasized that repeated exposure to painful stimuli during early stage of fundamental development of the nervous system leads to persistent behavioral and sensory changes [3]. Despite this fact, the use of appropriate pain relief interventions during potentially painful procedures is unusual in this population [4]. A paradox is still observed between the frequency of conditions that cause pain among young children and the use of appropriate pain relief intervention. The most often cited causes for this paradox are the several myths surrounding the painful experience in the neonatal population, particularly the perception that the newborn is too immature to feel pain [5]. It is known that the knowledge about the presence of pain in newborns has greatly increased among health providers who are responsible for neonatal care [6], but it is not known how each professional puts such knowledge into practice [7]. Young children including neonates do not have the ability to verbalize their pain thus health care providers must recognize their pain. Not only unmanaged pain causes distress and delayed recovery but pain in infancy also has short-term (physiological and behavioral) and long-term developmental consequences (increased or decreased behavioral responses to pain). Although infant’s pain is not expressed as conscious memory, memories of pain may be recorded biologically and alter brain development and subsequent behavior. Some recent studies have reported that simple and benign interventions such as oral sweet solutions [5, 8, 9], milk [10] or sucking a pacifier [11] reduce pain in neonates during procedures. Pain relieving effects of sweet solutions such as sucrose have been examined in term and preterm neonates [12, 13]. Glucose and other sweet tasting solutions have also been found to have pain relieving effects [9]. The effect of sugar on calming a crying baby during painful procedure is not new but there are historical references pertaining to the analgesic and calming benefits of sweet substances dating back to AD 632, when Prophet Mohammed recommended giving infants a well-chewed date [14]. Also Thorek, in his textbook, Modern Surgical Technique, published in 1938, explained his ideas of acceptable pediatric anesthesia: “Often no anesthesia is required. A sucker consisting of a sponge dipped in some sugar water will often suffice to calm a baby” [15].


2. Sweet solutions in the clinical settings and guidelines

The implementation of sweet solution for minor painful and invasive procedures in the NICU has been documented in many studies and extensive review of studies showed that sweet solutions have analgesic effects in young children up to one-year-old [16].

Study findings show that giving sweet solutions to young infants during painful procedures reduces painful responses and crying time tends to be shorter [9]. Different concentrations and dose were examined and showed to have a pain relieving effect. The most widely used sweet solution is sucrose [17]. Glucose is the second most commonly used solution, as it is available as prepared solution at clinics and hospitals [9]. All sweet solutions are administered in the same way, on the infants’ lateral side of the tongue prior to or 2 min before the procedure through a syringe slowly over 30 s [9, 18]. Another administration technique is through the use of non-nutritive sucking using pacifier to improve its effectiveness [11, 19].

Sweet solution is a fast acting pain-relief intervention (within 10 seconds) [20]. Although there is no evidence yet about the dose-response effects [21], dose ranging from 0.5 to 2 mL of 12–24% strength show pain-relief effect [11, 22]. For premature neonates, dose is calculated in accordance to their weight/volume ratio. Table 1 displays the doses according to week’s gestation and kilograms. In preterm neonates, it is recommended to use multiple dose regimens instead of given one dose to reduce any risk of adverse effects such as chocking. Several clinical guidelines included the use of sweet solution for analgesia particularly for minor painful procedures. Heel lance followed by venipuncture were the top benefiting procedures of this analgesic measure [2527]. Sweet solution may be used in infants aged 27 or more-week gestation. The volume administered for each age group should be as follow: 27–31 weeks’ gestation (0.1–0.5 mL); 32–36 weeks’ gestation (0.5–1 mL) and greater than 37 weeks’ gestation (1–2 mL) [5, 8, 9]. Dosage is usually expressed in mg. It is recommended to record the given dose and time on the neonates’ medication sheet. Sweet solution does not need a doctor’s order but it could be given by a nurse as needed, which is prepared in the pharmacy if not readily available in sterile container at floors. Once the container is open, the solution may be kept at the bedside for 24 hours if not Contaminated. It is important to record the opening date and time on the container. Sweet solution should not be used on infants less than 27-week gestations, infants who have suspected or proven gastrointestinal dysfunction/abnormalities such as ileus, obstruction, necrotizing enterocolitis or who are postoperative. Sweet solution should not be used for unstable or compromised neonates. Table 2 lists the contraindications for the use of sweet solutions for analgesia.

Age group27–31 weeks32 to terms0–3 months
Suggested doses (single events)0.2 mL0.2–0.5 mL0.2–2 mL
Suggested doses (24 hours)1 mL2.5 mL5 mL
Suggested doses (in kg)0.5 mL/kg/dose0.5 mL/kg/dose0.5 mL/kg/dose

Table 1.

Doses according to week’s gestation and kilograms and the sweetener used.

Source: [23, 24].

  • Infants with known sucrose or fructose intolerance

  • Infants with sucrase-isomaltase deficiency (CSID)

  • Infants with glucose-galactose malabsorption

  • Infants who are less than 27 weeks’ gestational age

  • Infants who are critically ill

  • Infants with confirmed or suspected GIT pathology, such as necrotizing enterocolitis

  • Infants who are paralyzed or sedated

  • Infants with altered gag or swallow reflex

Table  2.

Contraindications for the use of sweet solution as analgesic.

Source: Refs. [28, 29].

Around the world more and more hospitals and clinics are implementing the use of sweet substances to reduce pain and discomfort among premature and mature infants. Yet important knowledge and research gaps concerning long-term analgesic effects of repeated administration of sweet solutions still exist. One reason could be related to the fact that the mechanism of sweet-taste-induced analgesia is still not precisely understood, which prevented the uptake of such intervention using research evidence from being used in practice.


3. Sweet solution analgesia in human studies

Sweet solution as analgesic for painful events performed on premature and full term infants is a true revolutionary, novel and relatively current idea [30, 31]. It took long time for the clinical community to recognize and accept the fact that this special group of people does feel pain and this pain has short- and long-term negative consequences [32]. Moreover, available treatments such as opioids were considered unsafe and fear of their adverse effects lead to under treatment or even no treatment at all even for invasive practices [33]. Another obstacle was the lack of proper pain assessment measures for infants and nonverbal children [34]. Physiological and behavioral responses to pain were observed [34], and this lead to the development of pain assessment tools appropriate for measuring premature and infants pain, one of these tools is the premature infant pain profile (PIPP) that is utilized to assess pain and effectiveness of pain management among premature infants [35].

Sweet solution analgesia has been used for painful procedures performed in the NICU, for immunization, injections and circumcision. Heel lances performed quite often in the NICU provoked less physiological and behavioral responses of pain when proceeded with 2 mL of oral sucrose solution of 50% [36]. Same had been noticed for other routinely applied procedures such as intravenous or arterial line insertion, lumbar puncture, tape removal and venipuncture [3739]. This analgesic effect also extends to even older infants; sucrose was also effective in lowering pain scores due to immunization for babies aged between 1 and 12 months [23, 40]. Sucrose was beneficial when paired with other analgesic for pain relief during circumcision, probably since circumcision is a more intensely painful procedure than other routine procedures undertaken at NICU, yet it gave a synergistic effect with other analgesic methods [41]. The concentration of the sweet agent also mattered; a more concentrated sugar solution was found to be a more effective analgesic than less concentrated ones [21].

Sucrose is the most widely used agent for sweet solution-induced analgesia, nevertheless, other sweeteners were also tried and found to be effective. Fructose, lactose, milk and non-caloric sweeteners had been used for analgesia, although less frequently [21]. Glucose 20–30% solution is effective for heel lance and venipuncture in preterm and term infants [42, 43]. Fructose was as effective as sucrose and both were more effective than glucose [31]. In humans, fructose is as sweet as sucrose and sweeter than glucose; this might explain why fructose and sucrose were more effective than glucose [44]. Non-caloric sweeteners were also as effective as sucrose in reducing pain due to procedures such as heel lance [45].

The effect of sweet solution in reducing pain and calming crying infants is restricted to oral administration [12], providing evidence that it is the taste of sweetness what causes analgesia and not the sugar itself. Further evidence comes from the observation that different sugars and even artificial sweeteners produce the same effect when given orally into the oral cavity. Activating sensory afferents in the oral cavity leads to pleasurable sensation or effect. This positive hedonic effect of sweet tasting substances induced analgesia further supports the theory that it is the taste of sweetness not the caloric value of the food [46].

The mechanism of this sweet-induced analgesia is not fully elucidated. While animal studies provided more convincing evidence for the involvement of the endogenous opioid system, human studies were equivocal [42, 47, 48]. Tolerance to repeated doses of glucose did not develop, and an opioid antagonist, naloxone, given before glucose did not diminish its analgesic effects. On the other hand, babies born to methadone-addict mothers did not respond to the calming effects of sucrose. Thus, so far the evidence support the idea that the mechanism of analgesia induction might be mediated via opioid and non-opioid pathways [8, 47].

This analgesic effect is short lived and repeat administration is needed for repeated procedures. Furthermore, this effect of sweet tasting solutions does not persist beyond infancy [21].This sweet taste–induced analgesia does not extend to adults, and it seems to be related to the degree of sweetness; thus higher sucrose concentration were preferred by children compared to adults [49]. One explanation is that as we grow, the positive hedonic value of sweet tasting substances decreases thus evoking less pleasure and less analgesia.

Other non-pharmacological methods were also studied, kangaroo mother care KMC was found to be mildly effective at lowering pain responses to heel lance in full and preterm neonates [50]. Skin-to-skin contact between infant and mother alleviated pain occurrence during heel lance as well [51].


4. Sweet solution analgesia in animal studies

Animal studies have shown an analgesic effect of sweet solutions during infancy similar to that of humans [52]. Sweet components of milk including sucrose, glucose or fructose have shown to alleviate neonatal pain [53, 54]. The analgesic effect of sweet solutions is confined to the intraoral route as sucrose reduces pain sensation when administered orally not when applied via gastric gavage [12]. The antinociceptive actions of these solutions are not due to intraoral infusion alone because they are not produced by water or lactose [54, 55].

The most commonly studied is the natural sweetener sucrose. Sucrose has a long history of calming and analgesic effect especially for neonatal pain. The first observation of sucrose pain modulating effects was obtained by Blass et al. 1987 who reported that contact with a small amount of sucrose solution on the tongue of infant rats rapidly increased the paw withdrawal latency (a measure of pain threshold) in a hot-plate test [56]. Sucrose-induced analgesia during infancy develops rapidly and persists for several minutes [57]. In addition, sucrose ingestion for a relatively long period of time produces analgesia [58, 59]. Acute sucrose-induced analgesia is age-dependent that means it occurs mainly during the pre-weaning period in rats [57].

Artificial sweeteners have also shown analgesic actions when administered orally. Chronic saccharin intake decreases pain sensitivity and increases pain threshold as measured in hotplate test [60]. Furthermore, acute saccharin administration for 5 hours resulted in analgesia that persists for 3 hours [61]. Aspartame, another sweetener, decreases pain sensitivity, and has shown to produce analgesic effects comparable with sucrose [62, 63].

Although the mechanisms behind sweet substances-induced analgesia are still not clearly defined; endogenous opioid system is implicated. Sweet palatable solutions augment morphine-induced analgesia [6467], this has suggested that sweet solutions ingestion is associated with the release of endogenous opioids, a mechanism which involves stimulation of gustatory sweet receptors [68]. This mechanism was supported by the observation that sucrose reduces pain sensation when administered orally not when applied via gastric gavage [12, 69]. Furthermore, naltrexone and naloxone, opioid antagonists, were shown to abolish the analgesic effect of sweet-tasting solutions [56, 7072] In addition, consuming palatable sweet substances increases endogenous β-endorphin activity in rat brain and in human plasma [69, 7375]. Besides, endogenous opioid system, other neurotransmitters and receptors are probably involved. One study revealed a major involvement of nicotinic cholinergic receptors in the sweet substance-induced analgesia as atropine (cholinergic antagonist) diminished sucrose-induced analgesia [76]. Other studies have shown the involvement of noradrenaline, serotonin and their receptors in the central modulation sweet substance-induced analgesia [71, 77, 78].

Likewise, sweet solutions ability to prevent, decrease or reverse unfavorable long-term effects of neonatal pain had been explored. Unpublished data and a previous study from our lab indicate that early pain experience increases pain sensitivity and impairs spatial memory during adulthood in rats; the interventions using sucrose or saccharin solution prevented these long-term consequences of neonatal pain [75].


5. Short- and long-term effects of using sweet solutions during infancy

The fear of adverse effects following the use of nutritive sweet solutions for analgesia for premature and mature infants might be a hindrance to implementing this analgesic method. Among possible short-term effects are the fear of effect of sweet intake on milk feeding afterward. Also the effect on body weight, weather an increase due to development of sweet tooth or a decrease due to decrease in appetite for healthy food such as milk. Of the long-term effects are potential negative effects on growth and development. Of more concern would be the neurodevelopmental deficits, such as attention/orientation and motor tasks, that might result of higher intake of sugar during infancy, particularly infants who spend lengthier time at the NICU and are exposed to multiple painful procedures daily, thus requiring several doses of sweet solutions. It has been calculated that the amount of sugar a preterm infant will ingest over a period of a few weeks at the NICU will be equivalent to half a can of coke ingested by a 1-year-old [48]. Since few studies have examined the potential adverse effects of sweet solutions given at infancy, the word is still not out. Despite that, studies have shown no short-term adverse effects, however developmental effects were not examined thoroughly enough to arrive at a conclusive conclusion.

Studies have proclaimed sweet solutions as safe with no or minimum immediate or long-term negative effects [48]. A few on the other hand have challenged this notion and claimed that many long- and short-term adverse effects are associated with the use of sweet solutions for pain management during infancy [79].

In conclusion, oral sucrose (0.5 mL/kg of a 25% solution, 2 min prior to acute painful procedures) for pain relief in preterm neonates was effective and safe, exhibiting no short-term adverse effects in weight gain and feeding patterns, during hospitalization and post discharge [80].


6. Conclusion

Pain due to procedures applied to premature infants has shown to affect, in a negative way, brain development. Newborns, particularly premature infants have brains and nervous systems that are still under development and are very vulnerable to any insults. The plasticity of the brain at this early age makes it ideal for external stimuli to have long lasting effects [1]. Thus it is logical to put forward the hypothesis that managing this pain will in addition to its pain reducing effects be useful in inhibiting or at least reducing the long term unfavorable effects of untreated pain.

Despite availability of analgesia and knowledge about infants’ pain, a gap still exists between theoretical knowledge and actual practice. Thus the availability of non-pharmacological analgesia is very important and might be the selling point for the use of analgesia for premature and mature infants [4].

In conclusion, using sweet solutions for pain management, particularly, for this special age group is probably effective and safe, and has the potential of reversing or decreasing long-term adverse effects of pain. More studies need to be done to further explore the safety and the dose of sweet solution for pain during infancy.


  1. 1. Brummelte S, Grunau RE, Chau V, Poskitt KJ, Brant R, Vinall J, et al. Procedural pain and brain development in premature newborns. Ann Neurol. 2012;71(3):385–96.
  2. 2. Anand KJS, Scalzo FM. Can adverse neonatal experiences alter brain development and subsequent behavior? Biol Neonate. 2000;77(2):69–82.
  3. 3. Grunau RE. Neonatal pain in very preterm infants: long-term effects on brain, neurodevelopment and pain reactivity. Rambam Maimonides Med J. 2013;4(4):e0025.
  4. 4. Prestes ACY, Balda RDCX, Dos Santos GMS, Rugolo LMSDS, Bentlin MR, Magalhães M, et al. Painful procedures and analgesia in the NICU: what has changed in the medical perception and practice in a ten-year period? J Pediatr (Rio J). 2016;92(1):88–95.
  5. 5. Stevens B, Yamada J, Lee GY, Ohlsson A. Sucrose for analgesia in newborn infants undergoing painful procedures. Cochrane Database of Systematic Reviews 2013, Issue 1. Art. No.: CD001069. DOI: 10.1002/14651858.CD001069.pub4.
  6. 6. Akuma AO, Jordan S. Pain management in neonates: a survey of nurses and doctors. J Adv Nurs. 2012;68(6):1288–301.
  7. 7. Lefrak L, Burch K, Caravantes R, Knoerlein K, DeNolf N, Duncan J, et al. Sucrose analgesia: identifying potentially better practices. Pediatrics. 2006;118(Supplement_2):S197–202.
  8. 8. Harrison D, Beggs S, Stevens B. Sucrose for procedural pain management in infants. Pediatrics. 2012;130(5):918–25.
  9. 9. Kassab M, Sheehy A, King M, Fowler C, Foureur M. A double-blind randomised controlled trial of 25% oral glucose for pain relief in 2-month old infants undergoing immunisation. Int J Nurs Stud. 2012;49(3):249–56.
  10. 10. Blass EM, Watt LB. Suckling- and sucrose-induced analgesia in human newborns. Pain. 1999;83(3):611–23.
  11. 11. Tsao JCI, Evans S, Meldrum M, Altman T, Zeltzer LK. A review of CAM for procedural pain in infancy: part I. Sucrose and non-nutritive sucking. Evidence-Based Complement Altern Med. 2008;5(4):371–81.
  12. 12. Ramenghi L, Evans DJ, Levene MI. “Sucrose analgesia”: absorptive mechanism or taste perception? Arch Dis Child Fetal Neonatal Ed. 1999;80:F146–7.
  13. 13. Haouari N, Wood C, Griffiths G, Levene M. The analgesic effect of sucrose in full term infants: a randomised controlled trial. BMJ. 1995;310(6993):1498–500.
  14. 14. Islamic Voice. Relief of pain: a medical discovery. [Internet]. 2002. Available from:
  15. 15. Thorek M. Modern surgical technique, Vol III. Monterial: Lippincott, 1938; 2021. As written by AM Unruh in her article, Voices from the past: ancient views of pain in childhood. Clin J Pain. 1992;8(249).
  16. 16. Kassab M, Foster JP, Foureur M, Fowler C. Sweet-tasting solutions for needle-related procedural pain in infants one month to one year of age. Cochrane Database of Systematic Reviews 2010, Issue 3. Art.No.: CD008411. DOI: 10.1002/14651858.CD008411.
  17. 17. Taddio A, Shah V, Hancock R, Basc RWS, Stephens D, Atenafu E, et al. Effectiveness of sucrose analgesia in newborns undergoing painful medical procedures. Can Med Assoc J. 2008;179(1):37–43.
  18. 18. Taddio A, Appleton M, Bortolussi R, Chambers C, Dubey V, Halperin S, et al. Reducing the pain of childhood vaccination: an evidence-based clinical practice guideline (summary). CMAJ. 2010;182(18):1989–95.
  19. 19. Pasek TA, Huber JM. Hospitalized infants who hurt: a sweet solution with oral sucrose. Crit Care Nurse. 2012;32(1):61–9.
  20. 20. Buscemi N, Vandermeer B, Curtis S. The cochrane library and procedural pain in children: an overview of reviews. Evid Based Child Health. 2008;3:260–79.
  21. 21. Harrison D, Bueno M, Yamada J, Adams-Webber T, Stevens B. Analgesic effects of sweet-tasting solutions for infants: current state of equipoise. Pediatrics. 2010;126(5):894–902.
  22. 22. Stevens BJ, Abbott LK, Yamada J, Harrison D, Stinson J, Taddio A, et al. Epidemiology and management of painful procedures in children in Canadian hospitals. CMAJ. 2011; 183 (7): E403-E410.
  23. 23. Harrison D, Stevens B, Bueno M, Yamada J, Adams-Webber T, Beyene J, et al. Efficacy of sweet solutions for analgesia in infants between 1 and 12 months of age: a systematic review. Arch Dis Child. 2010;95(6):406–13.
  24. 24. Kassab, M, Foster, J, Foureur, M, Fowler, C. (2012). Sweet-tasting solutions for needle-related procedural pain in infants one month to one year of age. Cochrane Pain, Palliative Support Care Group. DOI:10.1002/14651858.CD008411
  25. 25. Lago P, Garetti E, Merazzi D, Pieragostini L, Ancora G, Pirelli A, et al. Guidelines for procedural pain in the newborn. Acta Paediatr Int J Paediatr. 2009;98(6):932–9.
  26. 26. Taddio A, McMurtry CM, Shah V, Riddell PR, Chambers CT, Noel M, et al. Reducing the pain of childhood vaccination: an evidence- based clinical practice guideline (summary). CMAJ. 2010; 182(18): 1989-95..
  27. 27. Cincinnati Children’s Hospital Medical Center. Reducing pain for children and adolescents receiving injections. 2013;1–9.
  28. 28. Murki S and Subramanian S., “WHO|sucrose for analgesia in newborn infants undergoing painful procedures. RHL Commentary (Last Revised: 1 June 2011). The WHO Reproductive Health Library; Geneva: World Health Organization. World Health Organization, 2016.
  29. 29. UW Health, Pain care fast facts: 5-mimute clinical inservice sucrose analgesia for infants. n.d.,
  30. 30. Blass EM, Hoffmeyer LB. Sucrose as an analgesic for newborn infants. Pediatrics. 1991;87(2):215–8.
  31. 31. Blass, EM, Smith BA Differential effects of sucrose, fructose, glucose, and lactose on crying in 1- to 3-day-old human infants: qualitative and quantitative considerations. Dev Psychol. 1992;28(5):804–10.
  32. 32. Owens ME, Todt EH. Pain in infancy: neonatal reaction to a heel lance. Pain. 1984;20(1):77–86.
  33. 33. Johnston CC, Collinge JM, Henderson SJ, Anand KJ. A cross-sectional survey of pain and pharmacological analgesia in Canadian neonatal intensive care units. Clin J Pain. 1997;13(4):308–12.
  34. 34. Johnston CC, Strada ME. Acute pain response in infants: a multidimensional description. Pain. 1986;24(3):373–82.
  35. 35. Stevens B, Johnston C, Petryshen P, Taddio A. Premature infant pain profile: development and initial validation. Clin J Pain. 1996;12(1):13–22.
  36. 36. Bucher HU, Moser T, von Siebenthal K, Keel M, Wolf M, Duc G. Sucrose reduces pain reaction to heel lancing in preterm infants: a placebo-controlled, randomized and masked study. Pediatr Res. 1995;38(3):332–5.
  37. 37. Elserafya FA, Alsaedi SA, Louwrensc J, Bin Sadiqd B, Mersal AY. Oral sucrose and a pacifier for pain relief during simple procedures in preterm infants: a randomized controlled trial. Ann Saudi Med. 2009;29(3):184–8.
  38. 38. Stevens B, Yamada J, Beyene J, Gibbins S, Petryshen P, Stinson J, et al. Consistent management of repeated procedural pain with sucrose in preterm neonates: is it effective and safe for repeated use over time? Clin J Pain. 2005;21(6):543–8.
  39. 39. Rouben N, Kaur R, Rao KLN. Effect of sucrose in pain during venipuncture in infants. Nurs Midwifery Res J. 2013;9(4):152–9.
  40. 40. Barr RG, Young SN, Wright JH, Cassidy KL, Hendricks L, Bedard Y, et al. “Sucrose analgesia” and diphtheria-tetanus-pertussis immunizations at 2 and 4 months. Dev Behav Pediatr 1995;16(4):220–5.
  41. 41. Bellieni CV, Alagna MG, Buonocore G. Analgesia for infants’ circumcision. Ital J Pediatr. 2013;39(1):38.
  42. 42. Eriksson M, Finnstro O. Can daily repeated doses of orally administered glucose induce tolerance when given for neonatal pain relief ? Acta Paediatr. 2004;93(18):246–9.
  43. 43. Bueno M, Yamada J, Harrison D, Khan S, Ohlsson A, Adams-Webber T, et al. A systematic review and meta-analyses of nonsucrose sweet solutions for pain relief in neonates. Pain Res Manag. 2013;18(3):153–61.
  44. 44. Fernstrom JD, Munger SD, Sclafani A, de Araujo IE, Roberts A, Molinary S. Mechanisms for sweetness. J Nutr. 2012;142(6):1134S–41.
  45. 45. Ramenghi LA, Griffith GC, Wood CM, Levene MI. Effect of non-sucrose sweet tasting solution on neonatal heel prick responses. Arch Dis Child. 1996;4(74):129–32.
  46. 46. Foo H, Mason P. Analgesia accompanying food consumption requires ingestion of hedonic foods. J Neurosci. 2009;29(41):13053–62.
  47. 47. Gradin M, Schollin J. The role of endogenous opioids in mediating pain reduction by orally administered glucose among newborns. Pediatrics. 2005;115(4):1004–7.
  48. 48. Holsti L, Grunau RE. Considerations for using sucrose to reduce procedural pain in preterm infants. Pediatrics. 2010;125(5):1042–7.
  49. 49. Pepino MY, Mennella JA. Sucrose-induced analgesia is related to sweet preferences in children but not adults. Pain. 2005;119(1–3):210–8.
  50. 50. Johnston CC, Filion F, Campbell-yeo M, Goulet C, Bell L, Mcnaughton K, et al. Kangaroo mother care diminishes pain from heel lance in very preterm neonates : a crossover trial. BMC Pediatr. 2008;9(13):1–9.
  51. 51. Gray L, Watt L, Blass EM. Skin-to-skin contact is analgesic in healthy newborns. Pediatrics. 2000;105(1):e14.
  52. 52. Fitzgerald M, Shaw A, MacIntosh N. Postnatal development of the cutaneous flexor reflex: comparative study of preterm infants and newborn rat pups. Dev Med Child Neurol. 1988;30(4):520–6.
  53. 53. Blass EM, Fitzgerald E. Milk-induced analgesia and comforting in 10-day-old rats: opioid mediation. Pharmacol Biochem Behav. 1988;29(1):9–13.
  54. 54. Blass EM, Shide DJ. Some comparisons among the calming and pain-relieving effects of sucrose, glucose, fructose and lactose in infant rats. Chem Senses. 1994;19(3):239–49.
  55. 55. Ren K, Blass EM, Zhou Q, Dubner R. Suckling and sucrose ingestion suppress persistent hyperalgesia and spinal Fos expression after forepaw inflammation in infant rats. Proc Natl Acad Sci U S A 1997;94:1471–5.
  56. 56. Blass E, Fitzgerald E, Kehoe P. Interactions between sucrose, pain and isolation distress. Pharmacol Biochem Behav. 1987;26(3):483–9.
  57. 57. Anseloni VCZ, Weng HR, Terayama R, Letizia D, Davis BJ, Ren K, et al. Age-dependency of analgesia elicited by intraoral sucrose in acute and persistent pain models. Pain. 2002;97(1–2):93–103.
  58. 58. Segato FN, Castro-Souza C, Segato EN, Morato S, Coimbra NC. Sucrose ingestion causes opioid analgesia. Braz J Med Biol Res 1997;30:981–4.
  59. 59. Kanarek RB, Mandillo S, Wiatr C. Chronic sucrose intake augments antinociception induced by injections of mu but not kappa opioid receptor agonists into the periaqueductal gray matter in male and female rats. Brain Res. 2001;920(1–2):97–105.
  60. 60. Bergmann F, Cohen E, Lieblich I. Biphasic effects of chronic saccharin intake on pain responses of healthy and diabetic rats of two genetically selected strains. Psychopharmacology (Berl). 1984;82(3):248–51.
  61. 61. Suri M, Jain S, Mathur R. Pattern of biphasic response to various noxious stimuli in rats ingesting sucrose ad libitum. Physiol Behav. 2010;101(2):224–31.
  62. 62. Rani S, Gupta MC. Evaluation and comparison of antinociceptive activity of aspartame with sucrose. Pharmacol Rep. 2012;64(2):293–8.
  63. 63. Abdollahi M, Nikfar S, Abdoli N. Potentiation by nitric oxide synthase inhibitor and calcium channel blocker of aspartame-induced antinociception in the mouse formalin test. Fundam Clin Pharmacol. 2001;15(2):117–23.
  64. 64. Kanarek RB, White ES, Biegen MT, Marks-Kaufman R. Dietary influences on morphine-induced analgesia in rats. Pharmacol Biochem Behav. 1991;38(3):681–4.
  65. 65. D’Anci KE, Kanarek RB, Marks-Kaufman R. Beyond sweet taste: saccharin, sucrose, and polycose differ in their effects upon morphine-induced analgesia. Pharmacol Biochem Behav. 1997;56(3):341–5.
  66. 66. Abdollahi M, Nikfar S, Habibi L. Saccharin effects on morphine-induced antinociception in the mouse formalin test. Pharmacol Res. 2000;42(3):255–9.
  67. 67. Kanarek RB, Homoleski B. Modulation of morphine-induced antinociception by palatable solutions in male and female rats. Pharmacol Biochem Behav. 2000;66(3):653–9.
  68. 68. Anseloni VCZ, Ren K, Dubner R, Ennis M. A brainstem substrate for analgesia elicited by intraoral sucrose. Neuroscience. 2005;133(1):231–43.
  69. 69. Yamamoto T, Sako N, Maeda S. Effects of taste stimulation on beta-endorphin levels in rat cerebrospinal fluid and plasma. Physiol Behav. 2000;69(3):345–50.
  70. 70. De Freitas RL, Kübler JML, Elias-Filho DH, Coimbra NC. Antinociception induced by acute oral administration of sweet substance in young and adult rodents: the role of endogenous opioid peptides chemical mediators and μ 1-opioid receptors. Pharmacol Biochem Behav 2012;101:265–70.
  71. 71. Rebouças ECC, Segato EN, Kishi R, Freitas RL, Savoldi M, Morato S, et al. Effect of the blockade of mu1-opioid and 5HT2A-serotonergic/alpha1-noradrenergic receptors on sweet-substance-induced analgesia. Psychopharmacology (Berl). 2005;179:349–55.
  72. 72. Shahlaee A, Farahanchi A, Javadi S, Delfan B, Dehpour AR. Sucrose-induced analgesia in mice: Role of nitric oxide and opioid receptor-mediated system. Indian J Pharmacol. 2013;45(6):593–6.
  73. 73. Melchior JC, Rigaud D, Colas-Linhart N, Petiet A, Girard A, Apfelbaum M. Immunoreactive beta-endorphin increases after an aspartame chocolate drink in healthy human subjects. Physiol Behav. 1991;50(5):941–4.
  74. 74. Dum J, Gramsch C, Herz A. Activation of hypothalamic β-endorphin pools by reward induced by highly palatable food. Pharmacol Biochem Behav. 1983;18(3):443–7.
  75. 75. Nuseir KQ, Alzoubi KH, Alabwaini J, Khabour OF, Kassab MI. Sucrose-induced analgesia during early life modulates adulthood learning and memory formation. Physiol Behav 2015;145:84–90.
  76. 76. Irusta AE, Savoldi M, Kishi R, Resende GC, Freitas RL, Carvalho AD, et al. Psychopharmacological evidences for the involvement of muscarinic and nicotinic cholinergic receptors on sweet substance-induced analgesia in Rattus norvegicus. Neurosci Lett. 2001;305(2):115–8.
  77. 77. Miyase CI, Kishi R, De Freitas RL, Paz DA, Coimbra NC. Involvement of pre- and post-synaptic serotonergic receptors of dorsal raphe nucleus neural network in the control of the sweet-substance-induced analgesia in adult Rattus norvegicus (Rodentia, Muridae). Neurosci Lett. 2005;379(3):169–73.
  78. 78. Kishi R, Bongiovanni R, De Nadai TR, Freitas RL, De Oliveira R, Ferreira CMDR, et al. Dorsal raphe nucleus and locus coeruleus neural networks and the elaboration of the sweet-substance-induced antinociception. Neurosci Lett 2006;395:12–7.
  79. 79. Gaspardo CM, Miyase CI, Chimello JT, Martinez FE, Martins Linhares MB. Is pain relief equally efficacious and free of side effects with repeated doses of oral sucrose in preterm neonates? Pain. 2008;137(1):16–25.
  80. 80. Harrison DM. Oral sucrose for pain management in infants: myths and misconceptions. J Neonatal Nurs. 2008;14(2):39–46.
  81. 81. Linhares MBM, Gaspardo CM, Souza LO, Valeri BO, Martinez FE. Examining the side effects of sucrose for pain relief in preterm infants: a case-control study. Braz J Med Biol Res. 2014;47(6):527–32.

Written By

Khawla Nuseir, Manal Kassab and Mohammed Al-Azzani

Submitted: 20 May 2016 Reviewed: 27 October 2016 Published: 24 May 2017